Altimmune Inc (ALT)
$12.93
0.64 (4.72%)
19:58 EST
ALT Stock Quote Delayed 30 Minutes
Previous Close
-
Market Cap
449.27M
PE Ratio
-3.61
EPS
-3.58
Volume (Avg. Vol.)
1.13M
Day's Range
12.71 - 13.91
52-Week Range
1.60 - 35.10
Dividend & Yield
N/A (N/A)
ALT Stock Predictions, Articles, and Altimmune Inc News
- From InvestorPlace
- From the Web
2020 In Review — 9 Great (And Not-So-Great) Calls
Technology and biotech stocks brought in more winning picks than usual, thanks partly to the strong stock market. Here are some of my best calls.
Altimmune Earnings: ALT Stock Rises 7% Despite Rough Q2 Results
Altimmune earnings from Tuesday evening have ALT stock higher despite the company reporting rough figures for second quarter of FY2020.
Altimmune Earnings: ALT Stock Tumbles 12% on FY Miss
Altimmune (ALT) earnings for the biopharmaceutical company's fiscal year of 2019 have ALT stock taking a dive Friday after missing estimates.
Altimmune Stock Has Major Pipeline Potential
There's no guarantee of a coronavirus cure, but Altimmune stock is worth owning on hopes of an effective vaccine.
Altimmune News: ALT Stock Rockets 110% on Coronavirus Vaccine News
Altimmune (ALT) news for Monday includes positive news about a vaccine to treat the coronavirus from China have ALT stock soaring higher.
Altimmune News: ALT Stock Skyrockets on Positive Flu Vaccine Data
Altimmune news concerning the results from a Phase 2 extension study of the company's NasoVAX has ALT stock heading higher today.
Why Altimmune Stock Is Sliding Lower Today
Altimmune stock was falling hard Monday on news that the company is selling additional stock to investors in a new offering.
Why Altimmune Stock Is Skyrocketing Today
Altimmune stock (ALT) soared more than 285% following successful clinical trial data of a medication and a reverse split of common shares.
Navellier Ratings
Powered by Portfolio GraderTotal Grade
A
Strong Buy
